BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
(Reuters) — A French appeals court ruled on Thursday that Bayer AG’s Monsanto business was liable for the health problems of a farmer who had inhaled a weedkiller product.
The ruling in favor of farmer Paul Francois was announced in a statement by a plaintiffs group. A Bayer spokeswoman in France also confirmed the ruling.
“We take note of the decision in favor of Mr. Francois and are studying the full ruling,” the spokeswoman said.
Mr. Francois, who says he suffered neurological problems after accidentally inhaling the Lasso weedkiller in 2004, accused Monsanto of not providing adequate safety warnings.
In a decade-long legal battle, Mr. Francois won rulings against Monsanto in 2012 and 2015, before France’s top court overturned those decisions and ordered a new hearing.
The latest ruling on Thursday, however, did not determine compensation for the farmer.
The appeals court referred the matter to another court in the southeastern city of Lyon, the “Phyto-victimes” plantiffs group said. The group represents workers who claim health problems due to exposure to pesticides.
The ruling in the French case comes as Monsanto faces lawsuits in the United States over alleged cancer links to its glyphosate-based weedkillers.
Lasso was banned in France in 2007 after the product had already been withdrawn in some other countries.
It used a different active substance to glyphosate, the chemical contained in Monsanto’s best-selling weedkiller Roundup and the target of lawsuits in the United States.
The legal troubles surrounding glyphosate have contributed to Bayer losing about €30 billion ($33.83 billion) from its market value since last August. The German group’s chief executive said on Thursday it was “massively affected” by the litigation.
(Reuters) — Shares in Germany's Bayer AG fell more than 12% on Wednesday after a second U.S. jury ruled its Roundup weed killer caused cancer.